SCHEMBL8779094

SCHEMBL8779094

O=C1c2ccc(Cl)cc2CCC12CCCC2

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 9/20 0.57
HTR2A P28223 7/20 0.57
HTR2C P28335 7/20 0.57
HTR2B P41595 7/20 0.57
DRD2 P14416 7/20 0.57
SRD5A1 P18405 4/20 0.44
SRD5A2 P31213 2/20 0.41
METAP1 P53582 1/20 0.40
HTT P42858 1/20 0.40
PPOX P50336 1/20 0.38
AHR P35869 1/20 0.38
S100A4 P26447 1/20 0.37
TYMS P04818 1/20 0.37
F7 P08709 1/20 0.36
PARP1 P09874 1/20 0.36
F3 P13726 1/20 0.36
PARP10 Q53GL7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8779128 0.87 F7 (0.46) SIGMAR1HTR2AHTR2CHTR2BDRD2
SCHEMBL18845510 0.80 SIGMAR1 (0.46) SIGMAR1HTR2AHTR2CHTR2BDRD2
SCHEMBL8779058 0.80 METAP1 (0.40) SIGMAR1HTR2AHTR2CHTR2BDRD2
SCHEMBL8779030 0.79 SIGMAR1 (0.39) SIGMAR1HTR2AHTR2CHTR2BDRD2
SCHEMBL9587877 0.78 HTR2A (0.46) SIGMAR1HTR2AHTR2CHTR2BDRD2
SCHEMBL6843211 0.78 SIGMAR1 (0.66) SIGMAR1HTR2AHTR2CHTR2BDRD2
SCHEMBL6843242 0.77 SIGMAR1 (0.71) SIGMAR1HTR2AHTR2CHTR2BDRD2
SCHEMBL6836344 0.77 SIGMAR1 (0.64) SIGMAR1HTR2AHTR2CHTR2BDRD2
SCHEMBL8936189 0.77 DRD2 (0.45) SIGMAR1HTR2AHTR2CHTR2BDRD2
SCHEMBL18815844 0.76 SMN1; SMN2 (0.59) SIGMAR1HTR2AHTR2CHTR2BDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0606661-B1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists HOFFMANN LA ROCHE (CH) 1997-03-12 EP disclosed
US-5385947-A For prevention of nerve damage due to reduction of blood or oxygen supplies HOFFMANN-LA ROCHE INC. (US) 1995-01-31 US disclosed
EP-0606661-A1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists F. HOFFMANN-LA ROCHE AG (CH) 1994-07-20 EP disclosed